John W. Mellors

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Microbiology Biology
Google:
"John Mellors"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang M, Yoon J, Reisert H, et al. (2024) HIV-1-infected T cell clones are shared across cerebrospinal fluid and blood during ART. Jci Insight. 9
Anderko RR, DePuyt AE, Bronson R, et al. (2024) Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy. Journal of Immunology (Baltimore, Md. : 1950)
Crowell TA, Ritz J, Zheng L, et al. (2024) Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial. Aids (London, England)
Li JZ, Melberg M, Kittilson A, et al. (2024) Predictors of HIV rebound differ by timing of antiretroviral therapy initiation. Jci Insight. 9
VanderVeen LA, Selzer L, Moldt B, et al. (2023) HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection. Aids (London, England). 38: 607-610
Parikh UM, Penrose KJ, Heaps AL, et al. (2023) HIV Drug Resistance Assessment among Women who Seroconverted during the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial. Journal of Acquired Immune Deficiency Syndromes (1999)
Copertino DC, Holmberg CS, Weiler J, et al. (2023) The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells. Jci Insight
Botha JC, Demirov D, Gordijn C, et al. (2023) The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs. Mbio. e0111623
Nachega JB, Musoke P, Kilmarx PH, et al. (2023) Global HIV control: is the glass half empty or half full? The Lancet. Hiv
Nieves-Rosado HM, Jacobs JL, Naqvi A, et al. (2023) Tim-3 signaling contributes to the suppressive capacity of Treg from people with HIV on antiretroviral therapy. Journal of Leukocyte Biology
See more...